Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Blood Transfus
; 18(3): 163-166, 2020 05.
Article
in English
| MEDLINE | ID: covidwho-400777
ABSTRACT
Passive immunotherapy with plasma derived from convalescent patients recovering from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that blood establishments are ready to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution, and control of product use. This Position paper aims to give recommendations on the biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Plasma
/
Pneumonia, Viral
/
Immunization, Passive
/
Coronavirus Infections
/
Betacoronavirus
/
Antibodies, Viral
Type of study:
Experimental Studies
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Blood Transfus
Year:
2020
Document Type:
Article
Affiliation country:
2020.0124-20
Similar
MEDLINE
...
LILACS
LIS